Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has shared an update.
Recordati S.p.A. has updated its shareholders on the execution of its share buyback program, initiated on April 30, 2025, following a resolution from the Shareholders’ Meeting. The program aims to purchase shares to service stock options and performance share plans for the company’s management. As of May 2, 2025, Recordati has acquired 3,103 shares, bringing its total to 3,133,757 own shares, which is 1.499% of its share capital. This strategic move is part of Recordati’s broader efforts to enhance shareholder value and support its incentive plans.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, with roots in a family pharmacy in Northern Italy from the 1920s. The company offers therapeutic options in specialist and general medicine, as well as rare diseases, and operates in about 150 countries across the EMEA, Americas, and APAC regions with over 4,450 employees.
Average Trading Volume: 466,849
Technical Sentiment Signal: Buy
Current Market Cap: €10.88B
For an in-depth examination of REC stock, go to TipRanks’ Stock Analysis page.